A personal care composition comprising: a polymeric nitrone comprising polymerized units of: (a) acrylates of Formula I: wherein R 1 is H or CH 3; and R 2 is C 1 -C 6 alkyl, phenyl, hydroxy C 1 -C 6 alkyl, dihydroxy C 1 -C 6 alkyl, polyoxyalkylene, N,N-dimethylamino C 2 -C 6 alkyl, N,N-diethylamino C 2 -C 4 alkyl; and (b) nitrone-pendant esters of Formula II: wherein R 3 is H or -COOH; R 4 is H or CH 3; and Z is a nitrone substituent of Formula III: wherein R 5, R 6, R 7, R 8, and R 9 are independently H, -OH, C 1 -C 6 alkoxy, - COOH, -COO - M + or -O - M +, where M + is a sodium, potassium, or ammonium ion; and R 10, R 11, R 12, R 13, and R 14 are independently H, -OH, C 1 -C 6 alkoxy, -COOH, -COO - M + or -O - M +, where M + is a sodium, potassium, or ammonium ion, or a substituent of Formula IV: wherein R 15, R 16, R 17, R 18, and R 19 are independently H, -OH, C 1 -C 6 alkoxy, -COOH, -COO - M + or -O - M +, where M + is a sodium, potassium, or ammonium ion, wherein the ester of Formula II is attached to the nitrone of Formula III at either of the phenyl rings thereon, with the proviso that if R 10, R 11, R 12, R 13, or R 14 is a substituent of Formula IV, then the ester of Formula II is attached to the nitrone of Formula III at the phenyl ring opposite the ring on which the substituent of Formula IV is attached, and the proviso that not more than one of R 10, R 11, R 12, R 13, or R 14 can be a substituent of Formula IV, and the further proviso that at least two of R 5, R 6, R 7, R 8, R 9, R 10, R 11, R 12, R 13, R 14, R 15, R 16, R 17, R 18, and R 19 are - OH; and wherein the sum of m + n is a number from 10 to 50, and the ratio of m to n is from 1:1 to 20:1; and a dermatologically acceptable carrier. a polymeric nitrone comprising polymerized units of: (a) acrylates of Formula I: wherein R 1 is H or CH 3; and R 2 is C 1 -C 6 alkyl, phenyl, hydroxy C 1 -C 6 alkyl, dihydroxy C 1 -C 6 alkyl, polyoxyalkylene, N,N-dimethylamino C 2 -C 6 alkyl, N,N-diethylamino C 2 -C 4 alkyl; and (b) nitrone-pendant esters of Formula II: wherein R 3 is H or -COOH; R 4 is H or CH 3; and Z is a nitrone substituent of Formula III: wherein R 5, R 6, R 7, R 8, and R 9 are independently H, -OH, C 1 -C 6 alkoxy, - COOH, -COO - M + or -O - M +, where M + is a sodium, potassium, or ammonium ion; and R 10, R 11, R 12, R 13, and R 14 are independently H, -OH, C 1 -C 6 alkoxy, -COOH, -COO - M + or -O - M +, where M + is a sodium, potassium, or ammonium ion, or a substituent of Formula IV: wherein R 15, R 16, R 17, R 18, and R 19 are independently H, -OH, C 1 -C 6 alkoxy, -COOH, -COO - M + or -O - M +, where M + is a sodium, potassium, or ammonium ion, wherein the ester of Formula II is attached to the nitrone of Formula III at either of the phenyl rings thereon, with the proviso that if R 10, R 11, R 12, R 13, or R 14 is a substituent of Formula IV, then the ester of Formula II is attached to the nitrone of Formula III at the phenyl ring opposite the ring on which the substituent of Formula IV is attached, and the proviso that not more than one of R 10, R 11, R 12, R 13, or R 14 can be a substituent of Formula IV, and the further proviso that at least two of R 5, R 6, R 7, R 8, R 9, R 10, R 11, R 12, R 13, R 14, R 15, R 16, R 17, R 18, and R 19 are - OH; and wherein the sum of m + n is a number from 10 to 50, and the ratio of m to n is from 1:1 to 20:1; and (a) acrylates of Formula I: wherein R 1 is H or CH 3; and R 2 is C 1 -C 6 alkyl, phenyl, hydroxy C 1 -C 6 alkyl, dihydroxy C 1 -C 6 alkyl, polyoxyalkylene, N,N-dimethylamino C 2 -C 6 alkyl, N,N-diethylamino C 2 -C 4 alkyl; and R 1 is H or CH 3; and R 2 is C 1 -C 6 alkyl, phenyl, hydroxy C 1 -C 6 alkyl, dihydroxy C 1 -C 6 alkyl, polyoxyalkylene, N,N-dimethylamino C 2 -C 6 alkyl, N,N-diethylamino C 2 -C 4 alkyl; and (b) nitrone-pendant esters of Formula II: wherein R 3 is H or -COOH; R 4 is H or CH 3; and Z is a nitrone substituent of Formula III: wherein R 5, R 6, R 7, R 8, and R 9 are independently H, -OH, C 1 -C 6 alkoxy, - COOH, -COO - M + or -O - M +, where M + is a sodium, potassium, or ammonium ion; and R 10, R 11, R 12, R 13, and R 14 are independently H, -OH, C 1 -C 6 alkoxy, -COOH, -COO - M + or -O - M +, where M + is a sodium, potassium, or ammonium ion, or a substituent of Formula IV: wherein R 15, R 16, R 17, R 18, and R 19 are independently H, -OH, C 1 -C 6 alkoxy, -COOH, -COO - M + or -O - M +, where M + is a sodium, potassium, or ammonium ion, R 3 is H or -COOH; R 4 is H or CH 3; and Z is a nitrone substituent of Formula III: R 5, R 6, R 7, R 8, and R 9 are independently H, -OH, C 1 -C 6 alkoxy, - COOH, -COO - M + or -O - M +, where M + is a sodium, potassium, or ammonium ion; and R 10, R 11, R 12, R 13, and R 14 are independently H, -OH, C 1 -C 6 alkoxy, -COOH, -COO - M + or -O - M +, where M + is a sodium, potassium, or ammonium ion, or a substituent of Formula IV: a dermatologically acceptable carrier.